GlycoMimetics is a biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs. Leveraging its expertise in carbohydrate chemistry, GlycoMimetics aims to advance innovative therapies for various diseases, including sickle cell disease and acute myeloid leukemia. Through its research and development efforts, the company is committed to making a meaningful impact on patients' lives and advancing the field of glycomimetic drug development.

Refer new talent to Glycomimetics